194
Participants
Start Date
July 23, 2018
Primary Completion Date
November 8, 2020
Study Completion Date
August 16, 2021
Colchicine group (experimental arm)
In the experimental group, patients will receive colchicine, starting with a loading dose of 2 mg at the time of revascularization and continuing with 0.5 mg twice daily (b.i.d) for 5 days.
Placebo group (control arm)
In the placebo group, patients will receive placebo, starting with a loading dose of 2 mg at the time of revascularization and continuing with 0.5 mg twice daily for 5 days.
Hôpital Louis Pradel, Bron
Centre Hospitalier Universitaire Angers, Angers
Hôpital Saint Joseph, Lyon
CHU Arnaud de Villeneuve, Montpellier
CHU de Mulhouse, Mulhouse
CHU de Poitiers, Poitiers
CHU de Rangueil, Toulouse
CHRU de Tours, Tours
Hospices Civils de Lyon
OTHER